• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 相关急性肾损伤的肾脏替代治疗:时机对死亡率的影响。

Kidney replacement therapy in COVID-19-Related acute kidney injury: The impact of timing on mortality.

机构信息

Division of Nephrology, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.

出版信息

PLoS One. 2024 Oct 24;19(10):e0309655. doi: 10.1371/journal.pone.0309655. eCollection 2024.

DOI:10.1371/journal.pone.0309655
PMID:39446912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11500876/
Abstract

The objective of this study was to determine the impact of the timing of KRT, dichotomized by a temporal criterion or by creatinine level, in patients with COVID-19-related AKI. This was a retrospective study involving 512 adult patients admitted to the ICU. All participants had laboratory-confirmed COVID-19 and a confirmed diagnosis of AKI. The potential predictors were the determination of the timing of KRT based on a temporal criterion (days since hospital admission) and that based on a serum creatinine cutoff criterion. Covariates included age, sex, and the SOFA score, as well as the need for mechanical ventilation and vasopressors. The main outcome measure was in-hospital mortality. We evaluated 512 patients, of whom 69.1% were men. The median age was 64 years. Of the 512 patients, 76.6% required dialysis after admission. The overall in-hospital mortality rate was 72.5%. When the timing of KRT was determined by the temporal criterion, the risk of in-hospital mortality was significantly higher for later KRT than for earlier KRT-84% higher in the univariate analysis (OR = 1.84, 95%, [CI]: 1.10-3.09) and 140% higher after adjustment for age, sex, and SOFA score (OR = 2.40, 95% CI: 1.36-4.24). When it was determined by the creatinine cutoff criterion, there was no such difference between high and low creatinine at KRT initiation. In patients with COVID-19-related AKI, earlier KRT might be associated with lower in-hospital mortality.

摘要

本研究旨在确定以时间标准或肌酐水平为标准对 COVID-19 相关 AKI 患者进行 KRT 的时机对其的影响。这是一项回顾性研究,共纳入 512 名入住 ICU 的成年患者。所有参与者均经实验室确诊为 COVID-19,且 AKI 诊断明确。潜在预测因子为基于时间标准(入院后天数)和基于血清肌酐截止值标准确定 KRT 的时机。协变量包括年龄、性别和 SOFA 评分,以及是否需要机械通气和血管加压药。主要结局指标为住院死亡率。我们评估了 512 例患者,其中 69.1%为男性。中位年龄为 64 岁。在 512 例患者中,76.6%在入院后需要透析。总的住院死亡率为 72.5%。当根据时间标准确定 KRT 时机时,与早期 KRT 相比,晚期 KRT 的住院死亡率风险显著更高,单因素分析中高出 84%(OR=1.84,95%[CI]:1.10-3.09),调整年龄、性别和 SOFA 评分后高出 140%(OR=2.40,95%CI:1.36-4.24)。当根据肌酐截止值标准确定时,在开始 KRT 时肌酐高低之间没有这种差异。在 COVID-19 相关 AKI 患者中,早期 KRT 可能与较低的住院死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dbc/11500876/80641b3aaa15/pone.0309655.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dbc/11500876/62a9e0f9ac03/pone.0309655.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dbc/11500876/22df2b51fb73/pone.0309655.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dbc/11500876/80641b3aaa15/pone.0309655.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dbc/11500876/62a9e0f9ac03/pone.0309655.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dbc/11500876/22df2b51fb73/pone.0309655.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dbc/11500876/80641b3aaa15/pone.0309655.g003.jpg

相似文献

1
Kidney replacement therapy in COVID-19-Related acute kidney injury: The impact of timing on mortality.COVID-19 相关急性肾损伤的肾脏替代治疗:时机对死亡率的影响。
PLoS One. 2024 Oct 24;19(10):e0309655. doi: 10.1371/journal.pone.0309655. eCollection 2024.
2
Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study.COVID-19 相关急性肾损伤行透析治疗的危重症患者的肾脏恢复和死亡:STOP-COVID 队列研究。
Am J Kidney Dis. 2022 Mar;79(3):404-416.e1. doi: 10.1053/j.ajkd.2021.11.004. Epub 2021 Dec 4.
3
Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients.MMCD 评分的制定和验证,以预测 COVID-19 患者的肾脏替代治疗。
BMC Med. 2022 Sep 2;20(1):324. doi: 10.1186/s12916-022-02503-0.
4
Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: renal replacement therapy and mortality. FRA-COVID SEN Registry Data.西班牙 COVID-19 相关急性肾损伤住院患者的特征:肾脏替代治疗和死亡率。FRA-COVID SEN 登记数据。
Nefrologia (Engl Ed). 2024 Jul-Aug;44(4):527-539. doi: 10.1016/j.nefroe.2023.03.017. Epub 2024 Aug 10.
5
Endothelial Dysfunction for Acute Kidney Injury in Coronavirus Disease 2019: How Concerned Should We Be?2019 年冠状病毒病急性肾损伤的血管内皮功能障碍:我们应该有多担心?
Nephron. 2021;145(5):513-517. doi: 10.1159/000515919. Epub 2021 May 27.
6
Utilization of Palliative Care for Patients with COVID-19 and Acute Kidney Injury during a COVID-19 Surge.在新冠疫情高峰期,COVID-19 合并急性肾损伤患者的姑息治疗利用情况。
Clin J Am Soc Nephrol. 2022 Mar;17(3):342-349. doi: 10.2215/CJN.11030821. Epub 2022 Feb 24.
7
Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.急性肾损伤和危重症 COVID-19 患者的肾脏替代治疗:危险因素和结局:巴西单中心经验。
Blood Purif. 2021;50(4-5):520-530. doi: 10.1159/000513425. Epub 2020 Dec 18.
8
Predicting the outcome of COVID-19 infection in kidney transplant recipients.预测肾移植受者 COVID-19 感染的结局。
BMC Nephrol. 2021 Mar 19;22(1):100. doi: 10.1186/s12882-021-02299-w.
9
Timing of kidney replacement therapy initiation for acute kidney injury.急性肾损伤患者肾脏替代治疗时机的选择。
Cochrane Database Syst Rev. 2022 Nov 23;11(11):CD010612. doi: 10.1002/14651858.CD010612.pub3.
10
Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.COVID-19 危重症患者合并急性肾损伤的临床特征和转归:一项单中心队列研究。
BMC Nephrol. 2021 Mar 15;22(1):92. doi: 10.1186/s12882-021-02296-z.

本文引用的文献

1
Mortality and mode of dialysis: meta-analysis and systematic review.死亡率和透析模式:荟萃分析和系统评价。
BMC Nephrol. 2024 Jan 3;25(1):1. doi: 10.1186/s12882-023-03435-4.
2
Timing of renal replacement therapy in patients with sepsis-associated acute kidney injury: A systematic review and meta-analysis.脓毒症相关性急性肾损伤患者肾脏替代治疗的时机:一项系统评价与荟萃分析。
Aust Crit Care. 2024 Mar;37(2):369-379. doi: 10.1016/j.aucc.2023.06.011. Epub 2023 Sep 19.
3
Biomarkers in acute kidney injury: On the cusp of a new era?急性肾损伤的生物标志物:新的时代即将到来?
J Clin Invest. 2023 Jul 3;133(13):e171431. doi: 10.1172/JCI171431.
4
Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury.为急性肾损伤的危重患者提供最佳肾脏替代治疗。
Intensive Care Med. 2022 Oct;48(10):1368-1381. doi: 10.1007/s00134-022-06851-6. Epub 2022 Sep 6.
5
Latin American registry of renal involvement in COVID-19 disease. The relevance of assessing proteinuria throughout the clinical course.拉丁美洲 COVID-19 疾病肾脏受累登记研究。在整个临床病程中评估蛋白尿的相关性。
PLoS One. 2022 Jan 27;17(1):e0261764. doi: 10.1371/journal.pone.0261764. eCollection 2022.
6
COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: A multicenter study in São Paulo, Brazil.巴西圣保罗多中心研究:重症监护病房接受肾脏替代治疗的 COVID-19 相关急性肾损伤患者。
PLoS One. 2022 Jan 14;17(1):e0261958. doi: 10.1371/journal.pone.0261958. eCollection 2022.
7
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.一种统一的肾小球滤过率估计方法:NKF-ASN 工作组关于重新评估种族在诊断肾脏疾病中的纳入的建议。
Am J Kidney Dis. 2022 Feb;79(2):268-288.e1. doi: 10.1053/j.ajkd.2021.08.003. Epub 2021 Sep 23.
8
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程,无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
9
Timing of Kidney Support Therapy in Acute Kidney Injury: What Are We Waiting For?急性肾损伤中肾脏支持治疗的时机:我们在等待什么?
Am J Kidney Dis. 2022 Mar;79(3):417-426. doi: 10.1053/j.ajkd.2021.07.014. Epub 2021 Aug 28.
10
Pathophysiology of COVID-19-associated acute kidney injury.COVID-19 相关急性肾损伤的病理生理学。
Nat Rev Nephrol. 2021 Nov;17(11):751-764. doi: 10.1038/s41581-021-00452-0. Epub 2021 Jul 5.